Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-07

Clinical Trial Update: Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating a four-drug induction regimen (vincristine, dexamethasone, doxorubicin, and PEG-asparaginase) with Metformin for relapsed childhood acu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adriamycin (doxorubicin) (doxorubicin)
  • DEXAMETHASONE (Dexamethasone)
  • Oncovin (vincristine) (vincristine)
  • Pegaspargase (pegaspargase)
  • metformin (metformin)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Acute Lymphoblastic Leukemia | Phase 1 | Status: COMPLETED